INNOVATIVE PHARMACEUTICAL BIOTECH LINNOVATIVE PHARMACEUTICAL BIOTECH LINNOVATIVE PHARMACEUTICAL BIOTECH L

INNOVATIVE PHARMACEUTICAL BIOTECH L

No trades
See on Supercharts

399 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Innovative Pharmaceutical Biotech Ltd. is an investment holding company, which engages in genetic testing, healthcare management, and distribution of bio-industrial products. The firm also focuses on developing insulin products that could be administered orally. It operates through the Trading of Beauty Products and Research and Development segments. The Trading of Beauty Products segment is involved in the trading of beauty products. The Research and Development segment includes research, development, and commercialization of the oral insulin product. The company was founded in 2000 and is headquartered in Hong Kong.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
399 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company